(1999). Carboxypeptidase A3 (CPA3): a novel gene highly induced by histone deacetylase inhibitors during differentiation of prostate epithelial cancer cells. Cancer Res
(2006). Case-control studies in the genomic era: a clinician's guide. Lancet Neurol
(2000). Catalona WJ: Genomewide scan for prostate cancer-aggressiveness loci.
(1993). PC: The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer [see comments].
(1997). Pearson JD: Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update [see comments] [published erratum appears in JAMA
(1999). Pretreatment Nomogram for Prostate-Specific Antigen Recurrence After Radical Prostatectomy or External-Beam Radiation Therapy for Clinically Localized Prostate Cancer.
(1998). PT: A Preoperative Nomogram for Disease Recurrence Following Radical Prostatectomy for Prostate Cancer.
The Veterans Administration Cooperative Research Group: Histologic Grading and Clinical Staging of Prostate Cancer.